Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions


Por: Metra, M, Tomasoni, D, Adamo, M, Anker, SD, Bayes-Genis, A, von Bardeleben, RS, Boehm, M, Donal, E, Filippatos, GS, Maisano, F, Ponikowski, P, Savarese, G, Praz, F and Butler, J

Publicada: 6 may 2025 Ahead of Print: 5 may 2025
Resumen:
Mitral regurgitation and tricuspid regurgitation are the most common valvular heart diseases in patients with heart failure and have independent prognostic value. Transcatheter interventions are now available for the treatment of valvular heart disease, and their efficacy and safety have been tested in randomized controlled trials. However, evidence is still limited and sometimes inconclusive because several aspects of these trials limit their interpretation or consistency. These include heterogeneity in the pathogenesis and clinical characteristics of patients, the dynamic nature of secondary atrioventricular valve disease severity, the role of heart failure medications and devices, dependency on procedural results and operators' skills, smaller number of patients enrolled and the power to detect differences in trials, and limitations to use patients' reported outcomes with unblinded study protocols. These specific aspects of trials in patients with atrioventricular valve disease are reviewed in this article with a focus on possible solutions to generate further evidence for the efficacy and safety for transcatheter treatments of atrioventricular valve disease in patients with heart failure.

Filiaciones:
Metra, M:
 Univ Brescia, Cardiol, ASST Spedali Civili, Brescia, Italy

 Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Brescia, Italy

Tomasoni, D:
 Univ Brescia, Cardiol, ASST Spedali Civili, Brescia, Italy

 Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Brescia, Italy

 Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden

Adamo, M:
 Univ Brescia, Cardiol, ASST Spedali Civili, Brescia, Italy

 Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Brescia, Italy

Anker, SD:
 Charite, German Ctr Cardiovasc Res DZHK, Dept Cardiol CVK, German Heart Ctr Charite,Partner Site Berlin, Berlin, Germany

:
 Hosp Univ Germans Trias i Pujol, Inst Cor, Barcelona, Spain

 Univ Autonoma Barcelona, Ctr Invest Biomed Red Enfermedades Cardiovasc CIBE, Dept Med, Barcelona, Spain

von Bardeleben, RS:
 Univ Med Johannes Gutenberg Univ, Heart Valve Ctr, Dept Cardiol, Mainz, Germany

Boehm, M:
 Saarland Univ Hosp, Dept Internal Med Clin 3, Homburg Saar, Germany

Donal, E:
 Univ Rennes, Inserm, LTSI UMR 1099, CHU Rennes, Rennes, France

Filippatos, GS:
 Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Cardiol, Athens, Greece

Maisano, F:
 Univ Vita Salute, IRCCS Osped San Raffaele, Valve Ctr, Cardiac Surg, Milan, Italy

Ponikowski, P:
 Wroclaw Med Univ, Inst Heart Dis, Wroclaw, Poland

 Univ Hosp, Inst Heart Dis, Wroclaw, Poland

Savarese, G:
 Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden

Praz, F:
 Univ Bern, Bern Univ Hosp, Dept Cardiol, Bern, Switzerland

Butler, J:
 Baylor Scott & White Res Inst, 3434 Live Oak St, Dallas, TX 75204 USA

 Univ Mississippi, Dept Med, Med Ctr, Jackson, MS USA
ISSN: 00097322





Circulation
Editorial
Lippincott Williams & Wilkins Ltd., TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA, Estados Unidos America
Tipo de documento: Review
Volumen: 151 Número: 18
Páginas: 1342-1363
WOS Id: 001524334100009
ID de PubMed: 40324027
imagen Bronze

MÉTRICAS